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Abstract
In the current study, we assessed the global DNA methylation changes in human lymphoblastoid (TK6) cells in vitro in
response to 5 direct and 10 indirect-acting genotoxic agents. TK6 cells were exposed to the selected agents for 24 h in the
presence and/or absence of S9 metabolic mix. Liquid chromatography-mass spectrometry was used for quantitative
profiling of 5-methyl-29-deoxycytidine. The effect of exposure on 5-methyl-29-deoxycytidine between control and exposed
cultures was assessed by applying the marginal model with correlated residuals on % global DNA methylation data. We
reported the induction of global DNA hypomethylation in TK6 cells in response to S9 metabolic mix, under the current
experimental settings. Benzene, hydroquinone, styrene, carbon tetrachloride and trichloroethylene induced global DNA
hypomethylation in TK6 cells. Furthermore, we showed that dose did not have an effect on global DNA methylation in TK6
cells. In conclusion we report changes in global DNA methylation as an early event in response to agents traditionally
considered as genotoxic.
Citation: Tabish AM, Poels K, Hoet P, Godderis L (2012) Epigenetic Factors in Cancer Risk: Effect of Chemical Carcinogens on Global DNA Methylation Pattern in
Human TK6 Cells. PLoS ONE 7(4): e34674. doi:10.1371/journal.pone.0034674
Editor: Lorenzo Chiariotti, Universita ` di Napoli Federico II, Italy
Received November 29, 2011; Accepted March 6, 2012; Published April 11, 2012
Copyright:  2012 Tabish et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Katholieke Universiteit Leuven Research Fund. The funders played no part in study design,data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Tabish.Ali@med.kuleuven.be
Introduction
Environmental carcinogens are a known risk factor of human
cancer [1]. In its classical model, carcinogenesis initiates and
proceeds through changes in the genome (i.e., genetic effects) [2].
Thus, measuring carcinogen-induced DNA damage i.e., DNA
adducts formation and cross-linking, and DNA mutations have
been employed in classic cancer risk assessment approaches, e.g.,
Ames test, comet assay and micronucleus assay [3–5]. Carcinogen-
induced DNA damage is an important early event during the
initiation phase of carcinogenesis, which reflects a permanent and
irreversible change in the initiated cells [6,7]. However, initiation
per se in a classical carcinogenesis model is not sufficient for tumor
development, which results from broader alterations in the cellular
homeostasis, mainly because of the inability of initiated cells to
properly control and regulate the gene expression [8].
Exposure to genotoxic carcinogens, in addition to their genetic
effects, might involve a variety of non-genotoxic effects in cells [9].
Non-genotoxic effects in cells may play an important role in cancer
development [10]. Evidence suggest that non-genotoxic alterations
in cells, e.g., alterations in cellular epigenome, could result in the
emergence of epigenetically reprogrammed cells [11]. These
epigenetically reprogrammed cells show an epigenetic profile
similar to that frequently observed in cancer cells, such as altered
histone modification patterns, hypomethylation of DNA repetitive
elements and proto-oncogenes and hypermethylation of tumor
suppressor genes. Altered epigenetic status confers genome
instability and loss of controlled growth signals, typically observed
in cancer cells [12]. Epigenetic alterations rather than specific
genetic mutations per se are reported for the clonal expansion of
altered hepatic preneoplastic foci and tumor development [13].
Recently, a number of studies reported that the carcinogenic
effects induced by 2-acetylaminofluorene, tamoxifen, trichloroeth-
ylene, aflatoxin B1, ochratoxin, nickel and chromium do not
follow a classical carcinogenesis model, but rather involve a
spectrum of cellular alterations encompassing the epigenetics.
[8,14–16]. Epigenetic factors play an important role in cancer
etiology; however, there is insufficient knowledge in linking
epigenetic factors to environmental carcinogenesis in premalignant
tissue [17]. Based on increasingly documented epigenetic changes
in cancer etiology, the goal of this study is to assess if alterations in
global DNA methylation are an early cellular event in response to
genotoxic carcinogens with a well-known mode of action (adducts
forming and cross-linking agents). In this study, we used 5 direct
and 10 indirect- acting genotoxic carcinogens to expose human
lymphoblastoid cells (TK6) for 24 h. TK6 cells were exposed to
carcinogens at 3 dose levels (low, medium and high) in duplicates.
S9 metabolic mix was added in cultures in half of the experiments
because indirect- acting carcinogens require S9 metabolic mix to
become functional carcinogens. We used human thymidine kinase
heterozygote TK6 cells in this study because they express wild-
type p53, grow rapidly in suspension (population doubling time of
12–14 h), and are routinely used in genetic toxicology studies.
After exposure, cells were harvested, DNA was extracted,
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TK6 cells.
Materials and Methods
Cell Culture
TK6 cells were purchased from the European Collection of Cell
Cultures (ECACC, Wiltshire, UK). Cells were divided into 15
treatment groups and 2 control groups (control S92, control S9+),
and cultured in RPMI 1640 medium containing 10% heat-
inactivated horse serum, 100 U/ml penicillin, 100 mg/ml strepto-
mycin and 2 mM l-glutamine at 5% CO2 and 37uC. Cells were
maintained at a density of 10
6 cells/ml and exposed for 24 h to
carcinogens. We set up two biological replicates per chemical dose,
10 control S92 replicates, and 5 control S9+ replicates.
Due to the requirement of enzymatic biotransformation of
procarcinogens to become active carcinogens, a mixture of S9 (1%
v/v) from human liver was added to the culture in half of the
experiments [18,19]. Liver S9 fractions were obtained from Celsis
(Neuss, Germany), and contained drug-metabolizing enzymes
including the cytochromes P450, flavin monooxygenases, and
UDP glucuronyl transferases. An exogenous NADPH-regenerat-
ing system (1.3 mM NADP+, 3.3 mM glucose-6-phosphate,
0.4 U/ml glucose-6-phosphate dehydrogenase, and 3.3 mM
magnesium chloride; BD Biosciences, Erembodegem, Belgium)
required by liver S9 for phase I oxidation was included in the
experiments. Cells were exposed to carcinogen in duplicates with
or without S9 metabolic mix.
Chemicals, Viability Assays and Dose Selection
We selected chemicals with well-described genotoxic character-
istics [20]. A list of the selected agents, their classification and
exposure dose is given in Table S1. All chemicals were purchased
from Sigma Aldrich, and dissolved and diluted in dimethylsulf-
oxide (DMSO). Viability assays were used to select doses per
agent. We used 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazo-
lium bromide (MTT) viability assay [21], and also counted the
proportions of living and dead cells using a Countess
TM
Automated Cell Counter (Invitrogen, Carlsbad, CA). Based on
the viability assays, we selected three doses per chemical, i.e. a
dose with 95% cellular viability (high dose), 1/10 of high dose
(medium dose) and 1/100 of high dose (low dose).
DNA Extraction, Concentration and Purity
After 24 h of treatment, cells were immediately processed for
DNA extraction. DNA was extracted using TrizolH reagent with
the PureLinkTM Micro-to-Midi SystemH according to the
manufacturer’s protocol (Invitrogen, Carlsbad, CA). DNA quan-
tity and quality was measured by NanoDrop Spectrophotometry
and Agilent 2100 bioanalyzer.
Enzymatic Hydrolysis of DNA
Extracted DNA was hydrolyzed to individual deoxyribonucleo-
sides in a simplified one-step procedure [22]. In short, DNA digest
mix was prepared by adding 250 U Benzonase (Sigma Aldrich),
300 mU Phosphodiesterase I (Sigma Aldrich), and 200 U alkaline
phosphatase (Sigma Aldrich) to 5 ml Tris-HCl buffer (pH 7.9,
20 mM) containing 100 mM NaCl and 20 mM MgCl2.1mgo f
extracted DNA from exposed and control samples was hydrolyzed
in 100 ml of reaction by adding 50 ml of digest mix, and samples
were incubated at 37uC for 6 h. Hydrolyzed samples were brought
to 1 ml by adding HPLC-grade H2O.
Calibration Standards
Calibration standards for 59methyl- deoxycytidine ((5Me)dC)
and deoxycytidine (dC) were purchased from Sigma, and dissolved
in LC-MS grade water (stock solutions). A calibration series was
prepared for 5(Me)dc and dC in a range of 0.1–10 ppb and 10–
100 ppb respectively from the stock solutions. The same
calibration standards were used in all of the experiments.
LC-ESI-MS/MS Instrumental Analysis
Global DNA methylation was obtained by quantifying (5Me)dC
and dC using ultra-pressure liquid chromatography (UPLC) for
fraction separation and tandem mass spectrometry (MS-MS) for
quantification. Analyses were carried out on Waters Acquity
UPLC equipped with autosampler and Micromass MS Technol-
ogies Quattro Premier mass spectrometer. A 10 ml sample was
introduced on an Acquity UPLC BEH C18,5 0m m 62.1 mm,
1.7 mm column, held at 40uC. Mobile phase used for chromato-
graphic separation was a mixture of 0.1% formic acid in water (A)
and 0.1% formic acid in acetonitrile (B) using the following
gradient: 0 min: 90% A and 10% B, 2–2.5 min: 100% B, 3.9–
4.0 min: 90% A and 10% B at a flow rate of 0.35 ml/min. All
mobile phase constituents were LC-MS grade and were purchased
from Biosolve (Valkenswaard, the Netherlands).
First, we performed full-scan spectrum under electrospray
ionization (ESI) conditions. In full scan spectrum, sodium adducts
5(Me)dC/dC [M+Na]+ and 5(Me)dC-dC dimers were also
observed, which is a common phenomenon in an ESI-MS full
scan [23]. Analyses were performed in ESI+ mode and a multiple
reaction monitoring (MRM) method was used with argon as the
collision gas at a pressure of 2.88 10
23 mbar. Transitions
monitored were m/z 242.00R125.85 for 5(Me)dC (cone voltage
14 V, collision energy 10 eV) and m/z 228.10R112.00 for dC
(cone voltage 14 V, collision energy 17 eV). Dwell time per
transition was 100 ms.
Calibration Curve
We observed linear response of standards over a range of
concentrations (0.1–10 ppb and 10–100 ppb) for 5(Me)dC and dC
with correlation coefficients of 0.9991 and 0.9970 respectively.
Statistics
The percentage of global DNA methylation was calculated per
chemical dose and is expressed as (5Me)dC/[(5Me)dC+dC] %.
We used marginal model to explore factors accounted for in the
observed variation in global DNA methylation in TK6 cells, i.e.,
chemicals, dose and S9. Residuals were plotted to verify the
assumptions of normality in the marginal model. The Shapiro-
Wilk test for residuals was shown to be non-significant, which
implied that approximating a response to a normal distribution
was appropriate. The SAS 9.2 statistical package was used to fit
the marginal model. Box plots were generated for chemicals with a
significant effect on global DNA methylation in TK6 cells using
SPSS v.18.
Results
Global DNA methylation in control and exposed cultures per
chemical dose without and with S9 metabolic mix is given in
Table 1 and 2 respectively. Our results show induction of global
DNA hypomethylation in response to S9 metabolic mix as shown
in Figure 1.
Variation in global DNA methylation of control and exposed
cultures demonstrated normal distribution (Figure S1). Assuming
global DNA methylation to be normally distributed, and
Effect of Carcinogens on Global DNA Methylation
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e34674Table 1. Global DNA methylation in TK6 cells per chemical dose in the absence of S9 metabolic mix.
Chemicals exposed to TK6 cells in vitro Global DNA Methylation in TK6 Cells (S92)
mean, +/2 SD
Low Dose Medium Dose High Dose
Control S92 6.38, +/21.21
Formaldehyde 4.09, +/20.23 5.21, +/20.57 4.61, +/20.23
Styrene 4.67
* 3.91, +/20.09 4.42
*
Styrene oxide 6.41
* 6.05, +/20.64 4.95, +/20.39
Benzene 4.71, +/20.06 4.31, +/20.61 4.51, +/20.03
Hydroquinone 3.71, +/20.21 3.51, +/20.42 5.31, +/20.57
Mitomycin C 7.23
* 4.52, +/20.12 6.35, +/20.63
Ethylenedibromide
** 3.41, +/20.37 3.29, +/20.43
Epichlorohydrin 3.81, +/20.72 4.44, +/20.57 4.42, +/20.62
Acrylamide 5.12, +/20.08 3.21, +/20.1 4.72, +/20.33
Trichloroethylene
** 5.32, +/20.13 5.91, +/20.3
Carbon tetrachloride 4.61, +/20.55 4.21, +/20.07 4.31, +/20.02
Cyclophosphamide
** 4.12, +/20.43 8.24
*
Benzo[a]fluoranthene 4.11, +/20.3 5.84, +/21.3
**
Benzo[a]pyrene 7.51, +/21.47 4.36, +/20.22 7.43, +/20.94
Benz[a]anthracene 6.55
* 3.74, +/20.08 6.09
*
Global DNA methylation is expressed as a percentage of 5-methylcytosine versus the total number of cytosines present in the genome.
SD: Standard deviation,
*standard deviation could not be calculated because sample replicates did not pass the quality control,
**global DNA methylation values are not calculated because samples did not pass the quality control.
doi:10.1371/journal.pone.0034674.t001
Table 2. Global DNA methylation in TK6 cells per chemical dose in the presence of S9 metabolic mix.
Chemicals exposed to TK6 cells in vitro Global DNA Methylation in TK6 Cells (S9+)
mean, +/2 SD
Low Dose Medium Dose High Dose
Control S9+ 4.46, +/20.83
Formaldehyde 4.61, +/20.44 4.55, +/20.43 4.23
*
Styrene 4.49, +/20.19 3.13, +/22.35 1.67
*
Styrene oxide 5.11
* 5.03, +/20.72 3.33
*
Benzene
** 2.92
* 3.99, +/20.05
Hydroquinone
** 4.36, +/20.37 1.77
*
Mitomycin C 5.16, +/20.51 5.17, +/20.31 6.22, +/20.51
Ethylenedibromide 5.24, +/21.27 4.53, +/20.06 4.09, +/20.29
Epichlorohydrin 3.89, +/20.51 4.62, +/20.62 3.85, +/20.14
Acrylamide 3.71
* 4.41, +/20.19 3.95, +/20.24
Trichloroethylene 3.61, +/22.65 1.72
* 2.59, +/20.74
Carbon tetrachloride
** 3.86, +/20.97 3.72
*
Cyclophosphamide
** 2.85, +/21.81 4.93
*
Benzo[a]fluoranthene 4.36, +/20.04 3.38, +/20.16 4.28, +/20.65
Benzo[a]pyrene 6.45
* 4.85, +/20.27 5.28, +/20.07
Benz[a]anthracene 4.16, +/20.75 4.95, +/20.66 4.62
*
Global DNA methylation is expressed as a percentage of 5-methylcytosine versus the total number of cytosines present in the genome.
SD: Standard deviation,
*standard deviation could not be calculated because sample replicates did not pass the quality control,
**global DNA methylation values are not calculated because samples did not pass the quality control.
doi:10.1371/journal.pone.0034674.t002
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replication within exposure to be correlated, a marginal model,
which captures this dependency, was applied. Covariance between
model residuals, which corresponds to uniform correlation within
repeated samples, was estimated to be 0.54. Ignoring the
correlation within replicated exposures could result in an in
accurate estimate of the significance of global DNA methylation.
In our results, we observed chemicals and S9 accounting for the
observed variability in global DNA methylation in TK6 cells
(Table S2). Dose was found to be non-significant even in the
absence of S9 in the marginal model. The model was refitted
excluding the dose and the results are given in Table 3.
Furthermore, we show that benzene and its metabolite
hydroquinone, and styrene, carbon tetrachloride and trichloro-
ethylene significantly affected the global DNA methylation in TK6
cells (Table 3). Global DNA methylation profiles observed with
exposure to these chemicals in TK6 cells without and with S9 are
shown in Figure 2 and 3 respectively.
Discussion
The classical theory of carcinogenesis is driven by genetic
mutations and chromosomal abnormalities conferring genome
instability [24,25]. However, the current study highlights the
importance of global DNA methylation as an early epigenetic
factor in response to genotoxic exposure.
Indirect- acting carcinogens require metabolic activation to
become reactive carcinogens. Due to the required metabolic
activation, a mixture of S9 liver extract (1% v/v) was added to half
of the cultures. S9 mixture contains enzymes required for phase-I
metabolic activation of xenobiotics. Expression of metabolic
enzymes is linked to reactive oxidative stress pathways [26].
Oxidative stress affects DNA methylation by altering the S-
adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH)
ratio [27–29]. In this study, the addition of S9 metabolic mix in
TK6 cell cultures resulted in global DNA hypomethylation
(b=20.9082, p,0.0001) (Table 3, Figure 1). S9-induced global
DNA hypomethylation in these cultures could be mechanistically
linked to the induction of oxidative stress pathways. Oxidative
stress activates cellular and nuclear signaling pathways, which
have intrinsic histone acetyltransferase (HAT) and histone
deacetylase (HADC) activities. In turn, these proteins are linked
to DNA methyltransferases (DNMTs) in the nuclear pathways
leading to the conformational changes in histones and chromatin
structure, and thus they alter the cellular transcription level
[30,31].
A number of chemicals used in this study affected global DNA
methylation changes in TK6 cells (Table 3, Figure 2 and 3). We
observed interesting global DNA methylation patterns. Benzene
(b=21.5289, p,0.0295) and it metabolite hydroquinone
(b=21.8029, p,0.0108) exposure induced global DNA hypo-
methylation in TK6 cells, while styrene exposure (b=21.7332,
p,0.0115) induced global DNA hypomethylation but its metab-
olite styrene oxide exposure did not affect the global DNA
methylation in TK6 cells (b=20.2999, p,0.6547). Benzene
exposure has shown to be linked to reduced methylation levels of
DNA repetitive elements [32]. Benzene and hydroquinone
exposure activates the oxidative stress pathways in cells which
affects the cellular DNA methylation pattern [33]. Styrene
exposure induces DNA adduct formation and oxidative stress in
cells [34]. Besides these effects, we report the induction of global
DNA hypomethylation by styrene as a potential non-genotoxic
mechanism, which could account for its toxicity. We also exposed
TK6 cells to carbon tetrachloride and trichloroethylene. These
chemicals mainly act through the formation of reactive interme-
diates after the metabolic activation. In the current study, we
observed global DNA hypomethylation induced by carbon
Table 3. The effect of S9 metabolic mix and carcinogens on
global DNA methylation in TK6 cells in vitro.
Effect Estimate Standard Error t-Value p-Value|
S9 20.9082 0.1956 24.64 ,. 0001
*
Formaldehyde 20.9032- 0.6676 21.35 0.1806
Styrene 21.7332 0.6676 22.60 0.0115
*
Styrene oxide 20.2999 0.6676 20.45 0.6547
Benzene 21.5289 0.6877 22.22 0.0295
*
Hydroquinone 21.8029 0.6877 22.62 0.0108
*
Mitomycin C 0.3268 0.6676 0.49 0.6261
Ethylenedibromide 20.9566 0.6676 21.43 0.1565
Epichlorohydrin 21.2766 0.6676 21.91 0.0601
Acrylamide 21.2649 0.6676 21.89 0.0624
Trichloroethylene 21.5302 0.6879 22.22 0.0294
*
Carbon tetrachloride 21.3879 0.6877 22.02 0.0475
*
Cyclophosphamide 20.4141 0.7163 20.58 0.5651
Benzo[a]fluoranthene 20.9712 0.6879 21.41 0.1626
Benzo[a]pyrene 0.5434 0.6676 0.81 0.4185
Benz[a]anthracene 20.4332 0.6676 20.65 0.5186
The table gives parameter estimates and standard errors for a random intercept
model with chemicals and S9 as fixed effects.
*Significant at a level of 0.05.
doi:10.1371/journal.pone.0034674.t003
Figure 1. Global DNA methylation in TK6 cells cultured without
S9 (control S92) and with S9 (control S9+) is shown in the box
plot. Global DNA methylation is expressed as a percentage of 5-
methylcytosine versus the total number of cytosines present in the
genome. The box plot describes the median (line across the box), inter-
quartile range and maximum and minimum values (whiskers). Outliers
are shown as open circles outside the ends of whiskers.
doi:10.1371/journal.pone.0034674.g001
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(b=21.5302, p,0.0294) exposure in TK6 cells (Table 3,
Figure 2 and 3). Previous studies also reported similar findings
about carbon tetrachloride and trichloroethylene (TCE) induced
global DNA hypomethylation. Carbon tetrachloride induced
global DNA hypomethylation was rescued by supplementation
with S-adenosylmethionine (SAM) in rat liver [35,36]. These
observations suggested that carbon tetrachloride induced DNA
hypomethylation involved methionine metabolic pathways. In
addition, these chemicals induce oxidative stress, which could
affect the cellular methylome.
In contrast to other studies, we did not observe global DNA
methylation changes in TK6 cells by exposure to poly-aromatic
hydrocarbons (PAHs). Chronic exposure of benzo[a]pyrene to
Figure 2. Box plot representation of global DNA methylation in control TK6 cells and TK6 cells exposed with benzene,
hydroquinone, styrene, carbon tetrachloride and trichloroethylene without S9 metabolic mix. Global DNA methylation is expressed as
percentage of 5-methylcytosine versus the total number of cytosines present in the genome. The box plot describes the median (line across the box),
inter-quartile range and maximum and minimum values (whiskers). Outliers are shown as open circles outside the ends of whiskers.
doi:10.1371/journal.pone.0034674.g002
Figure 3. Box plot representation of global DNA methylation in control TK6 cells and TK6 cells exposed with benzene,
hydroquinone, styrene, carbon tetrachloride and trichloroethylene with S9 metabolic mix. Global DNA methylation is expressed as
percentage of 5-methylcytosine versus the total number of cytosines present in the genome. The box plot describes the median (line across the box),
inter-quartile range and maximum and minimum values (whiskers). Outliers are shown as open circles outside the ends of whiskers.
doi:10.1371/journal.pone.0034674.g003
Effect of Carcinogens on Global DNA Methylation
PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e34674mouse embryonic fibroblasts in vitro induced global DNA
hypermethylation [37]. Also, differences in DNA methylation
levels have been reported in peripheral blood lymphocytes of
workers chronically exposed to PAH compared to their matched
controls [38]. Different experimental settings used in these studies
compared to the current study could explain the heterogeneity
observed in PAHs induced DNA methylation changes. Further-
more, no global DNA methylation changes in TK6 cells were
observed for mitomycin C, formalin, cyclophosphamide, ethyle-
nedibromide, epichlorohydrin and acrylamide. Global DNA
methylation changes in response to these chemicals have not
been reported elsewhere. Subtle epigenetic effects, such as histone
modifications and gene specific DNA methylation, in response to
these chemicals could not be ignored and will be explored further.
Global DNA hypomethylation in TK6 cells induced by direct
and indirect- acting genotoxic carcinogens investigated in this
study could imply that cells are under pre-neoplastic conditions. If
sustained global DNA hypomethylation persists, this could drive
these cells to neoplastic phenotype. However, the duration and
extent of exposure required for sustained global DNA hypomethy-
lation to confer neoplastic phenotype needs to be fully understood.
Conclusion
In conclusion, we report the non-genotoxic effect, i.e., alteration
in global DNA methylation, in response to a number of
carcinogens, which are traditionally considered to act through
genotoxic mechanisms. We also describe that S9 metabolic mix
alters the global DNA methylation pattern in TK6 cells. Future
work will address the dose-dependent effects of S9 metabolic mix
in vitro and the pathways involved in carcinogen-induced DNA
methylation changes. Our results suggest the use of different cell
lines and more varied assays to validate the above findings, and to
explore the mechanistic links.
Supporting Information
Figure S1 Histogram and density plot of residuals to
assess normality. Normality assumption of response (global
DNA methylation) was assessed by plotting the residuals (x-axis).
The plot appears to indicate that this assumption is plausible.
Shapiro-Wilk test was also performed to confirm normality and
residuals were shown to be non-significant.
(TIF)
Table S1 Overview of agents, their classification and
administered doses used in the treatment of TK6 cells.
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Table S2 Results of the marginal model describing the
effect of exposure, i.e., chemicals, dose, and S9, on
global DNA methylation in TK6 cells in vitro.
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